Targeted Medical Pharma, Inc. (OTCQB:TRGM), today announced financial results for its third quarter ended September 30, 2013. The Company posted increased revenues, gross profit and a reduction in net loss before interest, taxes, depreciation and amortization, stock based compensation, and non-recurring expenses (Adjusted EBITDA) on both a year-over-year and a quarterly basis.
Help employers find you! Check out all the jobs and post your resume.
